Augmented medial rectus recession versus botulinum toxin therapy for acute acquired comitant esotropia: analysis of outcomes and recurrence predictors.

چکیده

To compare the motor and sensory outcomes and quality of life (QOL) of augmented medial rectus recession (aMRc) and botulinum toxin A (BTXA) therapy in acute acquired comitant esotropia (AACE) treatment and to investigate the predictors of recurrence. We conducted a prospective, non-randomised…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط